Ahn-Gook Pharmaceutical Co. Ltd (001540) — Cash Flow Quality Index
Ahn-Gook Pharmaceutical Co. Ltd (001540) has a Cash Flow Quality Index of 4.29x as of September 2025. Operating cash flow of ₩14.44 Billion exceeds net income of ₩3.37 Billion, indicating high earnings quality where cash backs reported profits. Explore Ahn-Gook Pharmaceutical Co. Ltd (001540) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Ahn-Gook Pharmaceutical Co. Ltd Cash Flow Quality Index (2012–2024)
Historical Cash Flow Quality Index for Ahn-Gook Pharmaceutical Co. Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Ahn-Gook Pharmaceutical Co. Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Ahn-Gook Pharmaceutical Co. Ltd (2012–2024)
Year-by-year earnings quality comparison for Ahn-Gook Pharmaceutical Co. Ltd. For live market cap and the full company financial profile, see 001540 company net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.30x | ₩4.91 Billion | ₩16.34 Billion | ▲ +122.6% |
| 2023 | -1.33x | ₩-1.33 Billion | ₩998.28 Million | ▼ -611.3% |
| 2022 | 0.26x | ₩1.79 Billion | ₩6.88 Billion | ▼ -30.4% |
| 2021 | 0.37x | ₩1.47 Billion | ₩3.94 Billion | ▼ -95.7% |
| 2019 | 8.71x | ₩22.08 Billion | ₩2.54 Billion | ▲ +9683.0% |
| 2018 | -0.09x | ₩-1.20 Billion | ₩13.22 Billion | ▼ -104.2% |
| 2017 | 2.14x | ₩17.46 Billion | ₩8.16 Billion | ▼ -77.4% |
| 2016 | 9.47x | ₩12.62 Billion | ₩1.33 Billion | ▲ +341.0% |
| 2015 | 2.15x | ₩19.11 Billion | ₩8.90 Billion | ▲ +284.7% |
| 2013 | 0.56x | ₩3.64 Billion | ₩6.52 Billion | ▼ -82.4% |
| 2012 | 3.18x | ₩11.51 Billion | ₩3.63 Billion | — |